Right on! I've brought that up here before but as usual it falls on deaf ears. Quote: "And what were the results of the low dose control arm of just Ifosfamide without CiaB? There was no such control arm in the study. There is no basis for saying it's "BETTER". "
Market Data 
Markets 
AI
